Celldex Therapeutics, Inc.

CLDX · XNAS

CIK 744218fmd_06QSYRP78VPN2PNK730G9FWRQRManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.